glp-1 and type 1 diabetes vs. GLP-1 + GIP: What's the Difference for your Metabolism? More people with type 1

Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, et al

B vitamins support general metabolic health, but the claim that lipotropic injections meaningfully accelerate GLP-1-induced weight loss lacks rigorous scientific support

The most commonly used nonbiologic DMARDs are: Methotrexate Sulfasalazine Hydroxychloroquine Leflunomide DMARDs used in patients whose disease does not respond to the initial medications include: Azathioprine Cyclosporine

The research indicates that those using Ozempic may be more than twice as likely to develop NAION compared to patients taking other diabetes medications

nidulans wild-type and A

February 2026 marked a meaningful expansion in the oral GLP-1 landscape, with new data adding to the momentum that began with the FDA approval of oral Wegovy (semaglutide 25 mg tablets) in late 2025